Therapeutic Delivery – Products
Product News
Thermo Fisher Scientific Introduces Invitrogen™ Vivofectamine™ Delivery Solutions To Help Advance Life Science Research and Genetic Medicines
Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.
Product News
Aptamer Extends Agreement With Genetic Medicines Customer
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders, is pleased to announce that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.
Product News
Evotec and Bristol Myers Squibb Expand Proteomics Partnership
Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced progress within the Company’s strategic partnership with Bristol Myers Squibb relating to building a molecular glue-based pipeline.
Product News
Lonza Extends Collaboration With Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza, announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs.
Product News
Thermo Fisher Scientific Showcases Expanded Biopharma Services, Capabilities and Innovations at CPHI Milan 2024
Thermo Fisher Scientific Inc., will showcase its latest innovations enabling the molecule-to-medicine journey and host a series of sessions that feature industry developments during CPHI Milan 2024, Oct. 8-10, in Milan, Italy.
Product
Advertisement
Comprehensive Solutions for Lipid Nanoparticle Research
The trusted lipid experts at Cayman Chemical provide industry-leading solutions for every stage of LNP R&D, from high-purity lipids and research-ready LNPs to LNP formulation, screening, and CGMP lipid manufacturing services.
Product News
BD Showcases Latest Drug Delivery Innovations at CPhI Milan 2024
BD (Becton, Dickinson and Company), will highlight its newest innovations in drug delivery systems at CPhI Milan 2024 on October 8th and 9th in Milan, Italy.
Product News
Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America
To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical companies, Thermo Fisher Scientific Inc. is expanding its oral solid dose (OSD) footprint with a $22-million total investment.
Product News
MaxCyte Signs Strategic Platform License With Kamau Therapeutics To Accelerate the Development of Cell Therapies for Genetic Diseases
Kamau to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its homology-directed repair (HDR) novel gene correction technology.
Product News
Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 Published in JITC
Transgene announces the publication in the Journal for ImmunoTherapy of Cancer (JITC) of a peer-reviewed article which illustrates that TG6050 induces profound immune remodeling of the tumor microenvironment in animal models.
Advertisement
